Histogenics Corporation
Biotechnology - Waltham, Massachusetts, United States
Histogenics Corporation Employees
Histogenics Corporation Senior Management
Histogenics Corporation Details
Histogenics was acquired by Ocugen, (Nasdaq: OCGN) on September 27, 2019.Histogenics (Nasdaq: HSGX) is a leader in personalized restorative cell therapies (RCT) for active living. Our first investigational product candidate, NeoCart® is a proprietary RCT that rebuilds a patient's own knee cartilage, treating pain at the source and potentially preventing progression to osteoarthritis (OA). Read our community guidelines: https://goo.gl/Qtusgh
Website:
histogenics.com
Employees:
51 - 200
HQ:
["(781) 547-7900","781-547-7900","(781) 547-4452"]
Location:
Waltham, Massachusetts, United States
Revenue:
Histogenics Corporation Technologies
Load Balancers
Apache
CMS
WordPress.org
Advertising Networks
Google AdSense
Hosting
Google Cloud Hosting
Other
Mobile Friendly